# Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors

> **NCT00096317** · PHASE1 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 29 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** ixabepilone
- **DRUG:** ketoconazole

## Key facts

- **NCT ID:** NCT00096317
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-12-05
- **Final completion:** 2005-12-05
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2018-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096317, "Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00096317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*